Caitong International Asset Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.7K Buy
1,248
+1,194
+2,211% +$22.9K ﹤0.01% 865
2026
Q1
$951 Buy
54
+25
+86% +$502 ﹤0.01% 1448
2025
Q4
$573 Buy
29
+22
+314% +$395 ﹤0.01% 1454
2025
Q3
$122 Sell
7
-769
-99% -$11.4K ﹤0.01% 1728
2025
Q2
$10.9K Buy
776
+730
+1,587% +$11.8K 0.01% 690
2025
Q1
$857 Sell
46
-2,862
-98% -$42.7K ﹤0.01% 1619
2024
Q4
$32.7K Buy
+2,908
New +$34K 0.03% 631

Other funds holding ALHC

Caitong International Asset Management's ALHC Position: Q2 2026 in Review

Caitong International Asset Management increased its Alignment Healthcare (ALHC) stake by 2,211% in Q2 2026, buying an estimated $22.9K and bringing the position to 1,248 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #865.

Caitong International Asset Management first reported a position in ALHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $32.7K in Q4 2024. 323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Caitong International Asset Management held 1,248 shares of Alignment Healthcare worth $29.7K as of Q2 2026.
  • Caitong International Asset Management bought 1,194 Alignment Healthcare shares in Q2 2026, an estimated $22.9K.
  • Alignment Healthcare made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #865 holding.
  • Caitong International Asset Management first reported a position in Alignment Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Caitong International Asset Management's Alignment Healthcare position peaked at $32.7K in Q4 2024.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.